Mostafa Kamal - Magellan Health Senior Vice President and General Manager
President
Mr. Mostafa Kamal is Chief Executive Officer of Magellan Rx Management of the MAGELLAN HEALTH, INC. Mr. Kamal previously served as senior vice president and general manager of Magellan Rx Management specialty pharmacy business, as well as its chief underwriting officer. From 2011 to 2014, Mr. Kamal was vice president of pricing, underwriting and analytics. Before joining the company, he served as director of strategy and analytics at Medco Health Solutions, Inc. . He currently serves as a director of the Pharmaceutical Care Management Association.. since 2015.
| Age | 36 |
| Tenure | 9 years |
| Phone | 800 642-1716 |
| Web | www.magellanhealth.com |
Magellan Health Management Efficiency
The company has return on total asset (ROA) of 0.54 % which means that it generated a profit of $0.54 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.16) %, meaning that it created substantial loss on money invested by shareholders. Magellan Health's management efficiency ratios could be used to measure how well Magellan Health manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 562.64 M in liabilities with Debt to Equity (D/E) ratio of 0.28, which may suggest the company is not taking enough advantage from borrowing. Magellan Health has a current ratio of 2.86, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Magellan Health until it has trouble settling it off, either with new capital or with free cash flow. So, Magellan Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Magellan Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Magellan to invest in growth at high rates of return. When we think about Magellan Health's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Steven Fitzgerald | Visteon Corp | 51 | |
| Markus Schupfner | Visteon Corp | 49 | |
| Keren Rubanenko | Radcom | 40 | |
| Christian Garcia | Visteon Corp | 54 | |
| Doug Field | Tesla Inc | 50 | |
| Kristin Trecker | Visteon Corp | 59 | |
| David Pettyes | Visteon Corp | 43 | |
| Hilik Itman | Radcom | 51 | |
| Primit Parikh | Transphorm Technology | 52 | |
| Jon McNeill | Tesla Inc | 48 | |
| Robert Vallance | Visteon Corp | 63 | |
| Sunil Bilolikar | Visteon Corp | 56 | |
| Brett Pynnonen | Visteon Corp | 55 | |
| Eric Branderiz | Tesla Inc | 50 | |
| Field | Tesla Inc | 49 | |
| Matthew Cole | Visteon Corp | 49 | |
Management Performance
| Return On Equity | -0.16 | |||
| Return On Asset | 0.54 |
Magellan Health Leadership Team
Elected by the shareholders, the Magellan Health's board of directors comprises two types of representatives: Magellan Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Magellan. The board's role is to monitor Magellan Health's management team and ensure that shareholders' interests are well served. Magellan Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Magellan Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Eran Broshy, Independent Director | ||
| Swati Abbott, Director | ||
| Mostafa Kamal, Senior Vice President and General Manager | ||
| Scott MacKenzie, Independent Director | ||
| Barry Smith, Chairman and CEO | ||
| Mary Sammons, Independent Director | ||
| Joe Bogdan, Senior Vice President Corporate Finance | ||
| Steven Shulman, Independent Director | ||
| Matthew Simas, Director | ||
| Perry Fine, Independent Director | ||
| Daniel Gregoire, General Counsel and Secretary | ||
| Kay James, Director | ||
| Srinivas Koushik, CTO | ||
| Leslie Norwalk, Independent Director | ||
| John Agwunobi, Independent Director | ||
| John Littel, Senior Vice President - Government Affairs and Communications | ||
| Michael Diament, Independent Director | ||
| William McBride, Independent Director | ||
| Guy Sansone, Independent Director | ||
| Peter Feld, Independent Director | ||
| Renie Shapiro, Senior Vice President Corporate Finance | ||
| Michael Ressner, Independent Director | ||
| Sanjeev Srivastava, CEO of Magellan Healthcare | ||
| Caskie LewisClapper, Chief Human Resource Officer |
Magellan Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Magellan Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.16 | |||
| Return On Asset | 0.54 | |||
| Profit Margin | 6.26 % | |||
| Operating Margin | 0.60 % | |||
| Current Valuation | 2.09 B | |||
| Shares Outstanding | 26.33 M | |||
| Shares Owned By Insiders | 1.64 % | |||
| Shares Owned By Institutions | 98.36 % | |||
| Number Of Shares Shorted | 1.16 M | |||
| Price To Earning | 8.49 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Magellan Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Magellan Health's short interest history, or implied volatility extrapolated from Magellan Health options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Magellan Stock
If you are still planning to invest in Magellan Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Magellan Health's history and understand the potential risks before investing.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stocks Directory Find actively traded stocks across global markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |